Cargando…

Economic Evaluation of Denosumab Compared with Zoledronic Acid in Hormone-Refractory Prostate Cancer Patients with Bone Metastases

Detalles Bibliográficos
Autores principales: Rader, Michael, Goessl, Carsten, Cong, Ze
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438122/
https://www.ncbi.nlm.nih.gov/pubmed/22235959
http://dx.doi.org/10.18553/jmcp.2012.18.1.74
_version_ 1785092718170472448
author Rader, Michael
Goessl, Carsten
Cong, Ze
author_facet Rader, Michael
Goessl, Carsten
Cong, Ze
author_sort Rader, Michael
collection PubMed
description
format Online
Article
Text
id pubmed-10438122
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Academy of Managed Care Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-104381222023-08-21 Economic Evaluation of Denosumab Compared with Zoledronic Acid in Hormone-Refractory Prostate Cancer Patients with Bone Metastases Rader, Michael Goessl, Carsten Cong, Ze J Manag Care Pharm Letters Academy of Managed Care Pharmacy 2012-01 /pmc/articles/PMC10438122/ /pubmed/22235959 http://dx.doi.org/10.18553/jmcp.2012.18.1.74 Text en Copyright © 2012, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Letters
Rader, Michael
Goessl, Carsten
Cong, Ze
Economic Evaluation of Denosumab Compared with Zoledronic Acid in Hormone-Refractory Prostate Cancer Patients with Bone Metastases
title Economic Evaluation of Denosumab Compared with Zoledronic Acid in Hormone-Refractory Prostate Cancer Patients with Bone Metastases
title_full Economic Evaluation of Denosumab Compared with Zoledronic Acid in Hormone-Refractory Prostate Cancer Patients with Bone Metastases
title_fullStr Economic Evaluation of Denosumab Compared with Zoledronic Acid in Hormone-Refractory Prostate Cancer Patients with Bone Metastases
title_full_unstemmed Economic Evaluation of Denosumab Compared with Zoledronic Acid in Hormone-Refractory Prostate Cancer Patients with Bone Metastases
title_short Economic Evaluation of Denosumab Compared with Zoledronic Acid in Hormone-Refractory Prostate Cancer Patients with Bone Metastases
title_sort economic evaluation of denosumab compared with zoledronic acid in hormone-refractory prostate cancer patients with bone metastases
topic Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438122/
https://www.ncbi.nlm.nih.gov/pubmed/22235959
http://dx.doi.org/10.18553/jmcp.2012.18.1.74
work_keys_str_mv AT radermichael economicevaluationofdenosumabcomparedwithzoledronicacidinhormonerefractoryprostatecancerpatientswithbonemetastases
AT goesslcarsten economicevaluationofdenosumabcomparedwithzoledronicacidinhormonerefractoryprostatecancerpatientswithbonemetastases
AT congze economicevaluationofdenosumabcomparedwithzoledronicacidinhormonerefractoryprostatecancerpatientswithbonemetastases